These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Therapeutic angiogenesis for ischemic diseases]. Aoki M; Morishita R Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688 [TBL] [Abstract][Full Text] [Related]
6. An update on angiogenic gene therapy: vascular endothelial growth factor and other directions. Ylä-Herttuala S Curr Opin Mol Ther; 2006 Aug; 8(4):295-300. PubMed ID: 16955692 [TBL] [Abstract][Full Text] [Related]
7. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation. Kupatt C; Hinkel R; Pfosser A; El-Aouni C; Wuchrer A; Fritz A; Globisch F; Thormann M; Horstkotte J; Lebherz C; Thein E; Banfi A; Boekstegers P J Am Coll Cardiol; 2010 Jul; 56(5):414-22. PubMed ID: 20650363 [TBL] [Abstract][Full Text] [Related]
8. [Worldwide experience and recent trends in gene therapy of ischaemic diseases]. Deev RV; Grigorian AS; Potapov IV; Kiselev SL; Isaev AA Angiol Sosud Khir; 2011; 17(2):145-54. PubMed ID: 21998874 [TBL] [Abstract][Full Text] [Related]
9. The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor--an alternative gene therapy. Celec P; Gardlík R; Pálffy R; Hodosy J; Stuchlík S; Drahovská H; Stuchlíková M; Minárik G; Lukács J; Jurkovicová I; Hulín I; Turna J; Jakubovský J; Kopáni M; Danisovic L; Jandzík D; Kúdela M; Yonemitsu Y Med Hypotheses; 2005; 64(3):505-11. PubMed ID: 15617857 [TBL] [Abstract][Full Text] [Related]
10. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Shah PB; Losordo DW Adv Genet; 2005; 54():339-61. PubMed ID: 16096018 [TBL] [Abstract][Full Text] [Related]
11. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia. Dai Q; Huang J; Klitzman B; Dong C; Goldschmidt-Clermont PJ; March KL; Rokovich J; Johnstone B; Rebar EJ; Spratt SK; Case CC; Kontos CD; Annex BH Circulation; 2004 Oct; 110(16):2467-75. PubMed ID: 15477407 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806 [TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction--an obstacle of therapeutic angiogenesis. Sun L; Bai Y; Du G Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic angiogenesis through intramuscular injection of the gene for vascular endothelial growth factor (VEGF)]. Banga JD Ned Tijdschr Geneeskd; 2000 Jan; 144(3):113-6. PubMed ID: 10674116 [TBL] [Abstract][Full Text] [Related]
15. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562 [TBL] [Abstract][Full Text] [Related]
16. Angiogenesis therapy in ischemic disease. Silvestre JS; Lévy BI Arch Mal Coeur Vaiss; 2002 Mar; 95(3):189-96. PubMed ID: 11998334 [TBL] [Abstract][Full Text] [Related]
17. [The latest review of therapeutic angiogenesis using angiogenic growth factors to peripheral arterial diseases]. Aoki M; Ogihara T; Morishita R Nihon Rinsho; 2002 Sep; 60(9):1845-55. PubMed ID: 12233086 [TBL] [Abstract][Full Text] [Related]
18. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433 [TBL] [Abstract][Full Text] [Related]
19. Low invasive angiogenic therapy for myocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene. Hagikura K; Fukuda N; Yokoyama S; Yuxin L; Kusumi Y; Matsumoto T; Ikeda Y; Kunimoto S; Takayama T; Jumabay M; Mitsumata M; Saito S; Hirayama A; Mugishima H Int J Cardiol; 2010 Jun; 142(1):56-64. PubMed ID: 19167769 [TBL] [Abstract][Full Text] [Related]